Adara Abdalah
Psychiatric/Mental Health · Davie, FLNPI 1295321412
Payments from drug & device makers
Across 101 payments — averaging $25.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$554
- Neurocrine Biosciences, Inc.$302
- Lundbeck LLC$283
- AbbVie$186
- Vanda Pharmaceuticals Inc.$137
- Avanir Pharmaceuticals, Inc.$124
- plus $975 from 16 others
What the payments were for
- Food & beverage$2,561100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 18 | $554 |
| Neurocrine Biosciences, Inc. | 8 | $302 |
| Lundbeck LLC | 11 | $283 |
| AbbVie | 8 | $186 |
| Vanda Pharmaceuticals Inc. | 5 | $137 |
| Avanir Pharmaceuticals, Inc. | 12 | $124 |
| Corium, LLC | 6 | $119 |
| Almatica Pharma LLC | 6 | $116 |
| Supernus Pharmaceuticals, Inc. | 1 | $114 |
| Alkermes, Inc. | 6 | $111 |
| Axsome Therapeutics, Inc. | 4 | $100 |
| Idorsia Pharmaceuticals US Inc | 1 | $86 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $82 |
| Acadia Pharmaceuticals Inc | 3 | $63 |
| Teva Pharmaceuticals USA, Inc. | 2 | $45 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $26 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| Collegium Pharmaceutical, Inc. | 1 | $23 |
| Johnson & Johnson | 1 | $19 |
| E.r. Squibb & Sons, L.L.C. | 1 | $18 |
| Neos Therapeutics, LP | 1 | $17 |
| TMS Neurohealth Centers Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,561 in reported general payments places this provider in the 75th percentile of 3,096 psychiatric/mental health providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RexultiBrexpiprazole | 12 | $4,440 |
| Duloxetine Hcl | 27 | $560 |
| Risperidone | 13 | $506 |
| Oxcarbazepine | 11 | $450 |
| Mirtazapine | 29 | $436 |
| Quetiapine Fumarate | 19 | $171 |
| Clonazepam | 14 | $116 |
| Sertraline Hcl | 20 | $110 |
| Trazodone Hcl | 12 | $89 |
| Hydroxyzine Hcl | 12 | $51 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Otsuka America Pharmaceutical, Inc.Rexulti | $23 | $4,44012 claims |
| Almatica Pharma LLCSertraline Hcl | $116 | $11020 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,096 psychiatric/mental health providers in Florida.
Other psychiatric/mental health in Davie
- Roger RiveraKissimmee$1.6M
- Bethanie Simmons BecilJacksonville$782K
- Hannah PhillipsMaitland$455K
- Cheedy JajaTampa$266K
- Scott DurrancePensacola$224K
- Eudaldo AponteHialeah$214K
- Heather WarrenTallahassee$172K
- Angela DavenportAlachua$83K
- Natalie MoodyWinter Haven$75K
- Kelli BridgmanNew Smyrna Beach$66K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.